Article Details

RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with MSN Pharmaceuticals

Retrieved on: 2021-03-25 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with MSN Pharmaceuticals. View article details on hiswai:

Excerpt

(Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AztraZeneca AB ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up